Charles Schwab Investment Management Inc Intra Cellular Therapies, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $527 Billion
  • Q4 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 906,646 shares of ITCI stock, worth $119 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
906,646
Previous 904,909 0.19%
Holding current value
$119 Million
Previous $66.2 Million 14.44%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025
BUY
$71.19 - $91.57 $123,657 - $159,057
1,737 Added 0.19%
906,646 $75.7 Million
Q3 2024

Nov 12, 2024
SELL
$67.99 - $80.84 $1.1 Million - $1.31 Million
-16,160 Reduced 1.75%
904,909 $66.2 Million
Q2 2024

Aug 12, 2024
SELL
$64.76 - $79.84 $5.49 Million - $6.77 Million
-84,779 Reduced 8.43%
921,069 $63.1 Million
Q1 2024

May 08, 2024
BUY
$64.37 - $75.65 $774,692 - $910,447
12,035 Added 1.21%
1,005,848 $69.6 Million
Q4 2023

Feb 06, 2024
BUY
$46.37 - $73.65 $876,346 - $1.39 Million
18,899 Added 1.94%
993,813 $71.2 Million
Q3 2023

Nov 08, 2023
BUY
$52.09 - $64.1 $13.5 Million - $16.6 Million
259,424 Added 36.26%
974,914 $50.8 Million
Q2 2023

Aug 09, 2023
BUY
$54.67 - $66.44 $880,241 - $1.07 Million
16,101 Added 2.3%
715,490 $45.3 Million
Q1 2023

May 11, 2023
BUY
$43.8 - $56.99 $113,222 - $147,319
2,585 Added 0.37%
699,389 $37.9 Million
Q4 2022

Feb 13, 2023
BUY
$44.07 - $54.45 $720,324 - $889,985
16,345 Added 2.4%
696,804 $36.9 Million
Q3 2022

Nov 14, 2022
BUY
$42.7 - $59.99 $2.34 Million - $3.28 Million
54,695 Added 8.74%
680,459 $31.7 Million
Q2 2022

Aug 15, 2022
BUY
$43.0 - $65.64 $775,161 - $1.18 Million
18,027 Added 2.97%
625,764 $35.7 Million
Q1 2022

May 13, 2022
BUY
$38.74 - $62.09 $3.46 Million - $5.54 Million
89,260 Added 17.22%
607,737 $37.2 Million
Q4 2021

Feb 11, 2022
BUY
$35.2 - $53.42 $315,990 - $479,551
8,977 Added 1.76%
518,477 $27.1 Million
Q3 2021

Nov 16, 2021
BUY
$28.72 - $42.49 $530,946 - $785,512
18,487 Added 3.77%
509,500 $19 Million
Q2 2021

Aug 16, 2021
BUY
$29.3 - $44.5 $465,254 - $706,615
15,879 Added 3.34%
491,013 $20 Million
Q1 2021

May 17, 2021
BUY
$30.8 - $39.51 $528,897 - $678,465
17,172 Added 3.75%
475,134 $16.1 Million
Q4 2020

Feb 16, 2021
BUY
$23.34 - $32.22 $340,507 - $470,057
14,589 Added 3.29%
457,962 $14.6 Million
Q3 2020

Nov 13, 2020
BUY
$17.61 - $31.86 $1.37 Million - $2.48 Million
77,997 Added 21.35%
443,373 $11.4 Million
Q2 2020

Aug 14, 2020
BUY
$14.35 - $26.64 $374,391 - $695,037
26,090 Added 7.69%
365,376 $9.38 Million
Q1 2020

May 15, 2020
BUY
$12.31 - $33.12 $740,594 - $1.99 Million
60,162 Added 21.55%
339,286 $5.22 Million
Q4 2019

Feb 07, 2020
BUY
$7.26 - $38.49 $37,526 - $198,954
5,169 Added 1.89%
279,124 $9.58 Million
Q3 2019

Nov 08, 2019
BUY
$7.47 - $14.03 $19,982 - $37,530
2,675 Added 0.99%
273,955 $2.05 Million
Q2 2019

Aug 09, 2019
BUY
$10.65 - $14.29 $41,961 - $56,302
3,940 Added 1.47%
271,280 $3.52 Million
Q1 2019

May 14, 2019
BUY
$10.9 - $14.09 $133,950 - $173,152
12,289 Added 4.82%
267,340 $3.26 Million
Q4 2018

Feb 14, 2019
SELL
$10.36 - $20.96 $33,607 - $67,994
-3,244 Reduced 1.26%
255,051 $2.91 Million
Q3 2018

Nov 13, 2018
BUY
$17.77 - $22.9 $268,646 - $346,202
15,118 Added 6.22%
258,295 $5.61 Million
Q2 2018

Aug 08, 2018
BUY
$17.33 - $23.4 $266,518 - $359,868
15,379 Added 6.75%
243,177 $4.3 Million
Q1 2018

May 07, 2018
BUY
$15.16 - $25.49 $96,372 - $162,039
6,357 Added 2.87%
227,798 $4.8 Million
Q4 2017

Jan 17, 2018
BUY
$14.27 - $16.79 $1.26 Million - $1.48 Million
88,258 Added 66.27%
221,441 $3.21 Million
Q3 2017

Nov 13, 2017
BUY
$10.77 - $22.1 $1.43 Million - $2.94 Million
133,183
133,183 $2.1 Million

Others Institutions Holding ITCI

# of Institutions
419
Shares Held
88.8M
Call Options Held
284K
Put Options Held
105K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $12.4B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email